Even though TP53 mutations have been reported in over 50% of human tumours [33], it was not possible to profile the TP53 status by molecular methods in the CRC-tissues utilized in our previous studies (Ian Tomlinson, personal communication) [28, 29]. Here, TP53 is linked to neoplasm.